FDA Approves Three Tests for Determining Appropriate Use of Skin Infection Drug

NEW YORK (360Dx) – Melinta Therapeutics said this week that the US Food and Drug Administration has cleared three antimicrobial susceptibility tests to help guide physicians in the use of Melinta's drug to treatment for bacterial skin and skin structure infections.